Literature DB >> 11695869

Chromatographic methods for product-profile analysis and isolation of oligosaccharides produced by heparinase-catalyzed depolymerization of heparin.

W L Chuang1, H McAllister, L Rabenstein.   

Abstract

A two-dimensional chromatography method for monitoring the formation of oligosaccharides produced by heparinase-catalyzed depolymerization of heparin is reported. In the first step of the two-dimensional method, the depolymerized heparin is size-fractionated by high-performance gel permeation chromatography (HPGPC). The size-uniform fractions are then separated on the basis of charge by strong anion-exchange (SAX) HPLC on a high resolution CarboPac PA1 column. To demonstrate application of the two-dimensional product-profile analysis method, data are presented for the heparinase I-catalyzed depolymerization of heparin in the absence and presence of histamine, a ligand that binds site-specifically to heparin. Results from the two-dimensional analysis indicate that histamine alters the extent of depolymerization and the product-profiles for the tetrasaccharide and hexasaccharide fractions. The use of CarboPac PA1 columns for the semi-preparative scale separation of oligosaccharides in size-uniform fractions isolated from depolymerized heparin by low-pressure (gravity flow) GPC is also reported. The semi-preparative scale CarboPac PA1 column gives high resolution and excellent reproducibility after repeated use over an extended period of time, making it possible to reliably combine fractions from multiple separations. The oligosaccharides are eluted from the CarboPac PA1 column with a NaCl gradient at relatively low pH (3 or 7) where they are stable. An efficient two-step procedure is described for desalting oligosaccharides separated

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695869     DOI: 10.1016/s0021-9673(01)01241-9

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  8 in total

1.  Scientific considerations in the review and approval of generic enoxaparin in the United States.

Authors:  Sau Lee; Andre Raw; Lawrence Yu; Robert Lionberger; Naiqi Ya; Daniela Verthelyi; Amy Rosenberg; Steve Kozlowski; Keith Webber; Janet Woodcock
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

2.  NMR methods to monitor the enzymatic depolymerization of heparin.

Authors:  John F K Limtiaco; Szabolcs Beni; Christopher J Jones; Derek J Langeslay; Cynthia K Larive
Journal:  Anal Bioanal Chem       Date:  2010-09-04       Impact factor: 4.142

3.  Analysis of glycosaminoglycan-derived disaccharides by capillary electrophoresis using laser-induced fluorescence detection.

Authors:  Yuqing Chang; Bo Yang; Xue Zhao; Robert J Linhardt
Journal:  Anal Biochem       Date:  2012-05-15       Impact factor: 3.365

4.  Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis.

Authors:  Bo Yang; Amanda Weyers; Jong Youn Baik; Eric Sterner; Susan Sharfstein; Shaker A Mousa; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  Anal Biochem       Date:  2011-04-15       Impact factor: 3.365

Review 5.  Hyphenated techniques for the analysis of heparin and heparan sulfate.

Authors:  Bo Yang; Kemal Solakyildirim; Yuqing Chang; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2010-09-19       Impact factor: 4.142

6.  Capillary electrophoresis for the analysis of glycosaminoglycan-derived disaccharides.

Authors:  Yuqing Chang; Bo Yang; Amanda Weyers; Robert J Linhardt
Journal:  Methods Mol Biol       Date:  2013

Review 7.  Analysis and characterization of heparin impurities.

Authors:  Szabolcs Beni; John F K Limtiaco; Cynthia K Larive
Journal:  Anal Bioanal Chem       Date:  2010-09-03       Impact factor: 4.142

8.  Glycosaminoglycans from Co-Products of «Scyliorhinus canicula»: Extraction and Purification in Reference to the European Pharmacopoeia Requirement.

Authors:  Nawras Talmoudi; Noureddine Ghariani; Saloua Sadok
Journal:  Biol Proced Online       Date:  2020-01-02       Impact factor: 3.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.